Related Experiment Video
Updated: May 9, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Developing a General Population Screening Programme for Paediatric Type 1 Diabetes: Evidence from a Qualitative Study
Lauren M Quinn1, Parth Narendran1,2, Kirandeep Bhavra3
1Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham B15 2TT, UK.
Insights
Parental involvement in the UK's new type 1 diabetes (T1D) screening program for children (ages 3-13) is key. Clear communication on benefits, less invasive tests, and support systems are crucial for successful implementation.
Area of Science:
- Pediatric Endocrinology
- Public Health Screening
- Qualitative Research Methods
Background:
- The UK has launched a prototype population-based screening program for type 1 diabetes (T1D) in children aged 3-13.
- Reliable tests and preventative treatments for T1D are now available.
- Understanding parental perspectives is vital for the ethical and sustainable implementation of this screening program.
Purpose of the Study:
- To explore parental views on the UK's new pediatric type 1 diabetes screening program.
- To identify factors that encourage and support parental involvement in the screening process.
Main Methods:
- Qualitative interviews were conducted with 38 parents.
- Data analysis utilized a "Burden of Screening" framework with three domains: pre-screening tasks, engagement factors, and consequences of participation.
Main Results:
- Parents emphasized the need for clear communication regarding T1D screening benefits to address anxiety.
- Preferences included less invasive testing, structured healthcare professional support, and peer support.
- Concerns were raised about potential overprotective behaviors and anxiety following a positive screening result.
Conclusions:
- Clear communication of T1D screening benefits is essential to improve uptake.
- Decision-support tools and targeted educational materials should be developed.
- Post-testing, parents desire peer support and psychological counseling access.
Introduction:
With reliable tests and preventative treatments now available the United Kingdom has introduced a prototype population-based paediatric (ages 3-13) screening programme for type 1 diabetes (T1D). To aid its ethical and sustainable implementation this work explores parental views around the concept of this programme to determine how their involvement might be encouraged and supported. Research Design and Methods. Qualitative interviews were undertaken with 38 parents and the data were analysed using a purposely developed "Burden of Screening" framework, which presented the data within three domains describing the various elements of screening participation; pre-screening tasks designated to participants; factors influencing engagement with screening; and consequences of screening participation.
Results:
Regarding pre-screening tasks designated to participants, the importance of clear communication about the condition were apparent with parents expressing uncertainty of the benefits of screening against the potential anxiety engendered. In factors influencing their engagement with screening participants described their preference for less invasive testing techniques, the reassurance of structured support from healthcare professionals inherent within the programme, and the potential benefit of peer support. Regarding the consequences of screening participation parents described how a positive result might lead to overly protective behaviours, and anxiety from watching and waiting for the onset of symptomatic T1D.
Conclusions:
The benefits of T1D screening need to be clearly communicated to facilitate uptake. To this end the use of decision-support tools and better targeted educational materials should be explored. Post-testing, parents expressed preferences for peer support and access to psychological counselling.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Preventive Healthcare Services

